Trial intelligence / Profile preview

Role of Testosterone and Dihydrotestosterone on Metabolism and Muscle Strength in FtM Transsexuals

2008-003251-74Phase 3Completed

Sponsor
Sant'Orsola-Malpighi University Hospital
Start
Jul 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of testosterone and dutasteride in gender dysphoria (GD), sponsored by Sant'Orsola-Malpighi University Hospital. Primary endpoint: Muscle metabolism and muscle strength. Started Jul 2008; status: completed.

02

Drugs

testosteronedutasteride
03

Conditions

gender dysphoria (GD)

Beyond the preview

Go deeper on 2008-003251-74.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-003251-74.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call